Funding for this research was provided by:
Canadian Institutes of Health Research (N/A)
University of Toronto Clinician Investigator Program (N/A)
Canadian Society of Endocrinology and Metabolism (N/A)
Royal College of Physicians and Surgeons of Canada (N/A)
Received: 22 July 2019
Accepted: 10 February 2020
First Online: 24 February 2020
Ethics approval and consent to participate
: The research was approved by the Chinese University of Hong Kong–New Territories East Cluster Clinical Research Ethics Committee.
: Not applicable.
: JCNC is the Chief Executive Officer, on a pro bono basis, of the Asia Diabetes Foundation (ADF) which is a non-profit research organization which designed and implemented the Joint Asia Diabetes Evaluation (JADE) Technology as an extension to the HKDR, under the governance of the CUHK Foundation.The HKDR was established as a research-driven quality improvement program initiated by the Chinese University of Hong Kong (CUHK)-Prince of Wales Hospital Diabetes Care and Research Team, supported by the Hong Kong Foundation for Research and Development in Diabetes established at CUHK. In 2007, this was merged with the web-based JADE Technology, complete with care protocols, risk stratification, personalized reporting and decision support. The JADE Technology was designed and implemented by the ADF to enable other clinics and hospitals to establish diabetes registers and contribute anonymized data for research purposes. The ADF was set up as a charitable research organization governed by the CUHK Foundation.